CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized, Open-Label, Multicenter Study Examining the Effects of Duration of Treatment of PEGASYS® in Combination With Daily COPEGUS® + Amantadine in Patients With Chronic HCV After Relapse to Previous (Peg)IFN + Ribavirin Therapy.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00299923
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:34:49.943211+00:00
Published At: 2007-03-09T00:00:00+00:00
Record Updated At: 2007-03-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis C, Chronic", "Relapse"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2007-03-09"
protocolSection.identificationModule.nctId: "NCT00299923"
protocolSection.identificationModule.officialTitle: "Randomized, Open-Label, Multicenter Study Examining the Effects of Duration of Treatment of PEGASYS\u00ae in Combination With Daily COPEGUS\u00ae + Amantadine in Patients With Chronic HCV After Relapse to Previous (Peg)IFN + Ribavirin Therapy."
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.